COX-2 and PPARgamma expression are potential markers of recurrence risk in mammary duct carcinoma in-situ (Q33317621)

25 July 2017

title

COX-2 and PPARgamma expression are potential markers of recurrence risk in mammary duct carcinoma in-situ (English)

1 reference

25 July 2017

5

Monica Morrow

1 reference

25 July 2017

Swati Kulkarni

1

1 reference

25 July 2017

Deepa B Patil

2

1 reference

25 July 2017

Leslie K Diaz

3

1 reference

25 July 2017

Elizabeth L Wiley

4

1 reference

25 July 2017

Seema A Khan

6

1 reference

25 July 2017

language of work or name

English

0 references

publication date

31 January 2008

1 reference

25 July 2017

1 reference

25 July 2017

volume

8

1 reference

25 July 2017

page(s)

36

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2407-8-36

25 July 2017

exact match

0 references

cites work

Identification of a basal-like subtype of breast ductal carcinoma in situ

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254431

Relationship between aromatase and cyclooxygenases in breast cancer: potential for new therapeutic approaches

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254431

Overexpression of cyclo-oxygenase-2 is an independent predictor of unfavourable outcome in node-negative breast cancer, but is not associated with protein kinase B (Akt) and mitogen-activated protein kinase (ERK1/2, p38) activation or with Her-2/neu

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254431

Survivin expression in in situ and invasive breast cancer relates to COX-2 expression and DCIS recurrence

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254431

Biological variables and prognosis of DCIS.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254431

COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254431

p21WAF1/CIP1 selectively controls the transcriptional activity of estrogen receptor alpha

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254431

Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254431

The role of COX-2 inhibition in breast cancer treatment and prevention

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254431

The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast: a study of a large cohort of patients treated with surgery alone

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254431

COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254431

Tissue microarray analyses of G1/S-regulatory proteins in ductal carcinoma in situ of the breast indicate that low cyclin D1 is associated with local recurrence

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254431

Immunohistochemical study of cell cycle regulatory proteins in intraductal breast carcinomas--a preliminary study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254431

The role of COX-2 in breast and cervical cancer.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254431

Peroxisome proliferator-activated receptor gamma and cancers

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254431

Her-2/neu gene amplification in ductal carcinoma in situ of the breast.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254431

Age at diagnosis and outcome for women with ductal carcinoma-in-situ of the breast: a critical review of the literature

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254431

Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254431

Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254431

Cyclooxygenase-2 is overexpressed in HER-2/neu-positive breast cancer: evidence for involvement of AP-1 and PEA3.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254431

Peroxisome proliferator-activated receptor-gamma: from adipogenesis to carcinogenesis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254431

Tissue microarray technology for high-throughput molecular profiling of cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254431

Cyclooxygenase-2 is overexpressed in human cervical cancer.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254431

PPAR-gamma agonists: therapeutic role in diabetes, inflammation and cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254431

Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254431

Prognostic and predictive value of p53 and p21 in breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254431

Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254431

Terminal differentiation of human breast cancer through PPAR gamma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254431

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254431

Prostaglandin E2 production and metabolism in human breast cancer cells and breast fibroblasts. Regulation by inflammatory mediators

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254431

Prognostic significance of HER-2 oncoprotein expression in breast cancer: a 30-year follow-up

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254431

Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254431

Biological markers that predict clinical recurrence in ductal carcinoma in situ of the breast

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-36

Pathobiologic findings in DCIS of the breast: morphologic features, angiogenesis, HER-2/neu and hormone receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-36

CXCR4 is expressed in ductal carcinoma in situ of the breast and in atypical ductal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-36

EGFR, HER-2/neu, cyclin D1, p21 and p53 in correlation to cell proliferation and steroid hormone receptor status in ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-36

Cyclooxygenase-2 expression: a potential prognostic and predictive marker for high-grade ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-36

Analysis of cyclooxygenase-2 expression in human breast cancer: high throughput tissue microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-36

Cyclooxygenase-2 expression correlates with diminished survival in invasive breast cancer treated with mastectomy and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-36

Use of the peroxisome proliferator-activated receptor (PPAR) gamma ligand troglitazone as treatment for refractory breast cancer: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-36

Expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-gamma and levels of prostaglandin E2 and 15-deoxy-delta12,14-prostaglandin J2 in human breast cancer and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-36

Expression of Cyclooxygenase-1 and -2 in Human Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-36

Cell biological factors in ductal carcinoma in situ (DCIS) of the breast-relationship to ipsilateral local recurrence and histopathological characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-36

Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-36

Construction and validation of tissue microarrays of ductal carcinoma in situ and terminal duct lobular units associated with invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-36

Absence of HER4 expression predicts recurrence of ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-36

Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-36

COX-2 overexpression increases motility and invasion of breast cancer cells.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254431

Expression of cyclooxygenase-2 in malignant and benign breast tumors.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254431

The peroxisome proliferator-activated receptor gamma is an inhibitor of ErbBs activity in human breast cancer cells

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254431

Breast-conserving therapy for ductal carcinoma in situ of the breast: the French Cancer Centers' experience

31 October 2018

1 reference

12 December 2020

The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast

1 reference

12 December 2020

Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis

1 reference

12 December 2020

Cyclin E, a potential prognostic marker for breast cancer

1 reference

12 December 2020

Pathology and clinical evolution of ductal carcinoma in situ (DCIS) of the breast

1 reference

12 December 2020

PPARgamma expression in breast cancer: clinical value and correlation with ERbeta

1 reference

12 December 2020

Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast

1 reference

12 December 2020

Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001

1 reference

12 December 2020

Pathologic findings from the Breast Cancer Surveillance Consortium: population-based outcomes in women undergoing biopsy after screening mammography

1 reference

12 December 2020

Peroxisome proliferator-activated receptor gamma in human breast carcinoma: a modulator of estrogenic actions

1 reference

12 December 2020

17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells

1 reference

12 December 2020

Peroxisome proliferator activated receptor-γ (PPAR-γ) mediates the action of gamma linolenic acid in breast cancer cells

1 reference

12 December 2020

Mammographically detected ductal carcinoma in situ of the breast treated with breast-conserving surgery and definitive breast irradiation: long-term outcome and prognostic significance of patient age and margin status

1 reference

12 December 2020

Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2407-8-36

1 reference

Dimensions Publication ID

25 July 2017

1051662080

0 references

Fatcat ID

release_vuhiav243neodcr5ucd3uwrzo4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vuhiav243neodcr5ucd3uwrzo4

24 November 2022

mapped directly with Wikidata item

PMC publication ID

2254431

1 reference

25 July 2017

1 reference